Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

531 ARTÍCULOS , VIENDO DEL 391 AL 405

Botulinum toxin therapy for neurological disorders: Serendipitous benefits on sleep quality and underlying mechanisms

Kuang G, Yu Q, Yu D, Liu L, Hu X, Liu H, Wang X, Li J, Huang J, Wang T, Cash AJ, Lin Z, Xiong N.

Sleep Med Rev. 2025 Dec;84:102181. doi: 10.1016/j.smrv.2025.102181. Epub 2025 Oct 1.

Generalized dystonia unraveled: Molecular mechanisms, diagnostic strategies, and treatment paradigms

Yarahmadi F, Shoiebi A, Shariati M, Zech M, Sadr-Nabavi A.

Neurol Sci. 2025 Nov;46(11):5657-5669. doi: 10.1007/s10072-025-08404-3. Epub 2025 Aug 22.

Purine Metabolism and Dystonia: Perspectives of a Long-Promised Relationship

Sorrentino U, O'Neill AG, Kollman JM, Jinnah HA, Zech M.

Ann Neurol. 2025 May;97(5):809-825. doi: 10.1002/ana.27227. Epub 2025 Mar 3.

Long-Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10-Year Follow-Up

Krause P, Mahlknecht P, Skogseid IM, Steigerwald F, Deuschl G, Erasmi R, Schnitzler A, Warnecke T, Müller J, Poewe W, Schneider GH, Vesper J, Warneke N, Eisner W, Prokop T, Müller JU, Volkmann J, Kühn AA; Deep‐Brain Stimulation for Dystonia Study Group.

Mov Disord. 2025 Jun;40(6):1098-1111. doi: 10.1002/mds.30130. Epub 2025 Feb 5.

Neuromodulation for Laryngeal Dystonia: A Systematic Review

Lee CW, Krüger MT, Akram H, Zrinzo L, Yang W, Hamilton N, Rubin JS, Birchall MA, Fishman JM.

J Voice. 2025 Mar 30:S0892-1997(25)00111-0. doi: 10.1016/j.jvoice.2025.03.017. Online ahead of print.

Motor Features of Parkinson's Disease

Tarakad A.

Neurol Clin. 2025 May;43(2):279-289. doi: 10.1016/j.ncl.2024.12.007. Epub 2025 Jan 22.

Rare but Relevant: Assessing Variants in Dystonia-linked Genes in Parkinson's Disease

Lange LM, Fang ZH, Screven L, Tan AH, Alcalay RN, Amouri R, Bovenzi R, Fenn M, Frost JLI, Jankovic J, Jasaityte S, Jaunmuktane Z, Jeon B, Keller Sarmiento IJ, Krüger R, Kuhlenbäumer G, Lin CH, Pavelka L, Periñan MT, Ben Sassi S, Schirinzi T, Shin JH, Shulman JM, Tay YW, Uitti R, Warner T, Wszolek ZK, Wu L, Wu RM, Zeuner KE, Blauwendraat C, Singleton A, Mencacci NE, Morris HR, Lim SY, Lohmann K, Klein C.

medRxiv [Preprint]. 2025 Jul 11:2025.07.10.25330831. doi: 10.1101/2025.07.10.25330831.

Localization modalities for botulinum neurotoxin injection

Karp BI, Ly A, Alter KE.

Toxicon. 2025 Sep;264:108460. doi: 10.1016/j.toxicon.2025.108460. Epub 2025 Jun 16.

Vagus Nerve Stimulation in Movement Disorders, from Principles to a Systematic Review of Evidence

Proietti F, Ottaviani MM, Burchi E, Vivacqua G, Anzini G, Ricciuti RA, Capone F, Macefield VG, Di Lazzaro V, Marano M.

Mov Disord. 2025 Dec;40(12):2559-2577. doi: 10.1002/mds.70044. Epub 2025 Sep 30.

Single-Interval and Rhythmic Temporal Prediction in Cervical Dystonia

Terranova S, Botta A, Putzolu M, Bonassi G, Cosentino C, Mezzarobba S, Ravizzotti E, Lagravinese G, Pelosin E, Di Biasio F, Marchese R, Avanzino L.

Mov Disord. 2025 Aug;40(8):1714-1718. doi: 10.1002/mds.30260. Epub 2025 Jun 5.

Botulinum toxin treatment of lingual dystonia, oromandibular dystonia and bruxism-A review and update

Comtesse SM, Tavassoli F, Jabbari B.

Toxicon. 2025 Nov;266:108503. doi: 10.1016/j.toxicon.2025.108503. Epub 2025 Jul 24.

Development and Preliminary Validation of a Parkinsonism-Dystonia Scale for Infants and Young Children

Pons R, Pearson TS, Perez-Dueñas B, Garcia-Cazorla A, Kurian MA, Dalivigka Z, Zouvelou V, Outsika C, Kokkinou E, Sigatullina-Bondarenko M, Darling A, O'Callaghan MDM, Spaull R, Steel DBD, Salamou E, Forjaz MJ, Rodriguez-Blazquez C.

Mov Disord. 2025 Aug;40(8):1669-1679. doi: 10.1002/mds.30219. Epub 2025 May 13.

KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation

Cif L, Demailly D, Lin JP, Barwick KE, Sa M, Abela L, Malhotra S, Chong WK, Steel D, Sanchis-Juan A, Ngoh A, Trump N, Meyer E, Vasques X, Rankin J, Allain MW, Applegate CD, Isfahani SA, Baleine J, Balint B, Bassetti JA, Baple EL, Bhatia KP, Blanchet C, Burglen L, Cambonie G, Seng EC, Bastaraud SC, Cyprien F, Coubes C, d'Hardemare V; Deciphering Developmental Disorders Study; Doja A, Dorison N, Doummar D, Dy-Hollins ME, Farrelly E, Fitzpatrick DR, Fearon C, Fieg EL, Fogel BL, Forman EB, Fox RG; Genomics England Research Consortium; Gahl WA, Galosi S, Gonzalez V, Graves TD, Gregory A, Hallett M, Hasegawa H, Hayflick SJ, Hamosh A, Hully M, Jansen S, Jeong SY, Krier JB, Krystal S, Kumar KR, Laurencin C, Lee H, Lesca G, François LL, Lynch T, Mahant N, Martinez-Agosto JA, Milesi C, Mills KA, Mondain M, Morales-Briceno H; NIHR BioResource; Ostergaard JR, Pal S, Pallais JC, Pavillard F, Perrigault PF, Petersen AK, Polo G, Poulen G, Rinne T, Roujeau T, Rogers C, Roubertie A, Sahagian M, Schaefer E, Selim L, Selway R, Sharma N, Signer R, Soldatos AG, Stevenson DA, Stewart F, Tchan M; Undiagnosed Diseases Network; Verma IC, de Vries BBA, Wilson JL, Wong DA, Zaitoun R, Zhen D, et al.

ArXiv [Preprint]. 2025 Feb 10:arXiv:2502.06320v1.

Botulinum Toxin for the Treatment of Tremors

Bellows S, Jankovic J.

Toxins (Basel). 2025 Aug 11;17(8):401. doi: 10.3390/toxins17080401.

Integrative Chemical Genetics Platform Identifies Condensate Modulators Linked to Neurological Disorders

Poch D, Mukherjee C, Mallik S, Todorow V, Kuiper EFE, Dhingra N, Surovtseva YV, Schlieker C.

bioRxiv [Preprint]. 2025 Jun 8:2025.06.07.658469. doi: 10.1101/2025.06.07.658469.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias